Orchestra BioMed Holdings, Inc. (OBIO) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$48.96M | +3.2% |
| 2024 | -$50.56M | -9.6% |
| 2023 | -$46.13M | -57.5% |
| 2022 | -$29.29M | -10653.7% |
| 2021 | -$272.4K | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$48.96M | +3.2% |
| 2024 | -$50.56M | -9.6% |
| 2023 | -$46.13M | -57.5% |
| 2022 | -$29.29M | -10653.7% |
| 2021 | -$272.4K | — |